Conrad V Simoben

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Venues

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents

European biophysics journal : EBJ

Molecules (Basel, Switzerland)

ChemMedChem

Martin Luther Universität Halle-Wittenberg Institut für Pharmazie (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Martin Luther Universität Halle-Wittenberg Institut für Pharmazie Oct 01 2016

Germany

PHD :: Medicinal Chemistry

University of Buea Faculty of Sciences Oct 04 2012 - Nov 16 2015

Cameroon

MSC :: Chemistry

University of Buea Faculty of Science Oct 04 2008 - Nov 16 2011

Cameroon

BSC :: Chemistry

Publications

Felicite Majoumo-Mbe, Neba Abongwa Sangbong, Alain Tadjong Tcho, Cyril T Namba-Nzanguim, Conrad V Simoben, Donatus Bekindaka Eni, Mustafa A Isa, Adi Narayana Reddy Poli, Joel A Cassel, Joseph M Salvino, Luis J Montaner, Ian Tietjen, Fidele Ntie-Kang
5-chloro-3-(2-(2,4-dinitrophenyl) hydrazono)indolin-2-one: synthesis, characterization, biochemical and computational screening against SARS-CoV-2. Chemicke zvesti 78 (6) (2024)
Donatus Bekindaka Eni, Joel A Cassel, Cyril T Namba-Nzanguim, Conrad V Simoben, Ian Tietjen, Ravikumar Akunuri, Joseph M Salvino, Fidele Ntie-Kang
Design, synthesis, and biochemical and computational screening of novel oxindole derivatives as inhibitors of Aurora A kinase and SARS-CoV-2 spike/host ACE2 interaction. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 33 (4) (2024)
Donatus Bekindaka Eni, Joel A Cassel, Cyril T Namba-Nzanguim, Conrad V Simoben, Ian Tietjen, Ravikumar Akunuri, Joseph M Salvino, Fidele Ntie-Kang
Design, synthesis, and biochemical and computational screening of novel oxindole derivatives as inhibitors of Aurora A kinase and SARS-CoV-2 spike/host ACE2 interaction. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 33 (4) (2024)
Boris Davy Bekono, Pascal Amoa Onguéné, Conrad V Simoben, Luc C O Owono, Fidele Ntie-Kang
Computational discovery of dual potential inhibitors of SARS-CoV-2 spike/ACE2 and M pro : 3D-pharmacophore, docking-based virtual screening, quantum mechanics and molecular dynamics. European biophysics journal : EBJ (2024)
Donatus Bekindaka Eni, Joel A Cassel, Cyril T Namba-Nzanguim, Conrad V Simoben, Ian Tietjen, Ravikumar Akunuri, Joseph M Salvino, Fidele Ntie-Kang
Design, synthesis, and biochemical and computational screening of novel oxindole derivatives as inhibitors of Aurora A kinase and SARS-CoV-2 spike/host ACE2 interaction. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 33 (4) (2024)
Donatus Bekindaka Eni, Joel A Cassel, Cyril T Namba-Nzanguim, Conrad V Simoben, Ian Tietjen, Ravikumar Akunuri, Joseph M Salvino, Fidele Ntie-Kang
Design, synthesis, and biochemical and computational screening of novel oxindole derivatives as inhibitors of Aurora A kinase and SARS-CoV-2 spike/host ACE2 interaction. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 33 (4) (2024)
Boris Davy Bekono, Pascal Amoa Onguéné, Conrad V Simoben, Luc C O Owono, Fidele Ntie-Kang
Computational discovery of dual potential inhibitors of SARS-CoV-2 spike/ACE2 and M pro : 3D-pharmacophore, docking-based virtual screening, quantum mechanics and molecular dynamics. European biophysics journal : EBJ 53 (5-6) (2024)
Boris Davy Bekono, Pascal Amoa Onguéné, Conrad V Simoben, Luc C O Owono, Fidele Ntie-Kang
Computational discovery of dual potential inhibitors of SARS-CoV-2 spike/ACE2 and M pro : 3D-pharmacophore, docking-based virtual screening, quantum mechanics and molecular dynamics. European biophysics journal : EBJ 53 (5-6) (2024)
Conrad V Simoben, Smith B Babiaka, Aurélien F A Moumbock, Cyril T Namba-Nzanguim, Donatus Bekindaka Eni, José Luis Medina-Franco, Stefan Günther, Fidele Ntie-Kang, Wolfgang Sippl
Challenges in natural product-based drug discovery assisted with in silico -based methods. RSC advances 13 (45) (2023)
Conrad V Simoben, Ehab Ghazy, Patrik Zeyen, Salma Darwish, Matthias Schmidt, Christophe Romier, Dina Robaa, Wolfgang Sippl
Binding Free Energy (BFE) Calculations and Quantitative Structure-Activity Relationship (QSAR) Analysis of Schistosoma mansoni Histone Deacetylase 8 (smHDAC8) Inhibitors. Molecules (Basel, Switzerland) 26 (9) (2021)
Jelena Melesina, Conrad V Simoben, Lucas Praetorius, Emre F Bülbül, Dina Robaa, Wolfgang Sippl
Strategies To Design Selective Histone Deacetylase Inhibitors. ChemMedChem 16 (9) (2021)
Smith B Babiaka, Conrad V Simoben, Kennedy O Abuga, James A Mbah, Rajshekhar Karpoormath, Dennis Ongarora, Hannington Mugo, Elvis Monya, Fidelis Cho-Ngwa, Wolfgang Sippl, E Joel Loveridge, Fidele Ntie-Kang
Alkaloids with Anti-Onchocercal Activity from Voacanga africana Stapf (Apocynaceae): Identification and Molecular Modeling. Molecules (Basel, Switzerland) 26 (1) (2020)
Conrad V Simoben, Dina Robaa, Alokta Chakrabarti, Karin Schmidtkunz, Martin Marek, Julien Lancelot, Srinivasaraghavan Kannan, Jelena Melesina, Tajith Baba Shaik, Raymond J Pierce, Christophe Romier, Manfred Jung, Wolfgang Sippl
A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing. Molecules (Basel, Switzerland) 23 (3) (2018)
Conrad V Simoben, Fidele Ntie-Kang, Sergi H Akone, Wolfgang Sippl
Compounds from African Medicinal Plants with Activities Against Selected Parasitic Diseases: Schistosomiasis, Trypanosomiasis and Leishmaniasis. Natural products and bioprospecting 8 (3) (2018)

Conrad V Simoben.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Conrad V Simoben